A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway

被引:111
作者
Aglipay, JA
Lee, SW
Okada, S
Fujiuchi, N
Ohtsuka, T
Kwak, JC
Wang, Y
Johnstone, RW
Deng, CX
Qin, J
Ouchi, T
机构
[1] NYU, Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA
[2] Beth Israel Deaconess Med Ctr, Canc Biol Program, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA
[5] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[6] Peter MacCallum Canc Inst, Trescowthick Res Labs, Melbourne, Vic, Australia
[7] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD USA
关键词
BRCA1; IFI16; p53; apoptosis;
D O I
10.1038/sj.onc.1207057
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We identified IFI16 as a BRCA1-associated protein involved in p53-mediated apoptosis. IFI16 contains the Pyrin/PAAD/DAPIN domain, commonly found in cell death-associated proteins. BRCA1 (aa 502-802) interacted with the IFI16 Pyrin domain (aa 1-130). We found that IFI16 was localized in the nucleoplasm and nucleoli. Clear nucleolar IFI16 localization was not observed in HCC1937 BRCA1 mutant cells, but reintroduction of wild-type BRCA1 restored IFI16 nuclear relocalization following IR (ionizing radiation). Coexpression of IFI16 and BRCA1 enhanced DNA damage-induced apoptosis in mouse embryonic fibroblasts from BRCA1 mutant mice expressing wild-type p53, although mutant IFI16 deficient in binding to BRCA1 did not induce apoptosis. Furthermore, tetracycline-induced IFI16 collaborated in inducing apoptosis when adenovirus p53 was expressed in DNA-damaged p53-deficient EJ cells. These results indicate a BRCA1-IFI16 role in p53-mediated transmission of DNA damage signals and apoptosis.
引用
收藏
页码:8931 / 8938
页数:8
相关论文
共 35 条
  • [1] Alberg Anthony J., 1997, Current Opinion in Oncology, V9, P505, DOI 10.1097/00001622-199711000-00003
  • [2] Apoptotic molecular machinery: Vastly increased complexity in vertebrates revealed by genome comparisons
    Aravind, L
    Dixit, VM
    Koonin, EV
    [J]. SCIENCE, 2001, 291 (5507) : 1279 - +
  • [3] A superfamily of conserved domains in DNA damage responsive cell cycle checkpoint proteins
    Bork, P
    Hofmann, K
    Bucher, P
    Neuwald, AF
    Altschul, SF
    Koonin, EV
    [J]. FASEB JOURNAL, 1997, 11 (01) : 68 - 76
  • [4] Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks
    Cortez, D
    Wang, Y
    Qin, J
    Elledge, SJ
    [J]. SCIENCE, 1999, 286 (5442) : 1162 - 1166
  • [5] Cloning a novel member of the human interferon-inducible gene family associated with control of tumorigenicity in a model of human melanoma
    DeYoung, KL
    Ray, ME
    Su, YA
    Anzick, SL
    Johnstone, RW
    Trapani, JA
    Meltzer, PS
    Trent, JM
    [J]. ONCOGENE, 1997, 15 (04) : 453 - 457
  • [6] The PYRIN domain: A member of the death domain-fold superfamily
    Fairbrother, WJ
    Gordon, NC
    Humke, EW
    O'Rourke, KM
    Starovasnik, MA
    Yin, JP
    Dixit, VM
    [J]. PROTEIN SCIENCE, 2001, 10 (09) : 1911 - 1918
  • [7] A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation
    Gu, W
    Malik, S
    Ito, M
    Yuan, CX
    Fondell, JD
    Zhang, XL
    Martinez, E
    Qin, J
    Roeder, RG
    [J]. MOLECULAR CELL, 1999, 3 (01) : 97 - 108
  • [8] Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1
    Harkin, DP
    Bean, JM
    Miklos, D
    Song, YH
    Truong, VB
    Englert, C
    Christians, FC
    Ellisen, LW
    Maheswaran, S
    Oliner, JD
    Haber, DA
    [J]. CELL, 1999, 97 (05) : 575 - 586
  • [9] The human interferon-inducible protein, IFI 16, is a repressor of transcription
    Johnstone, RW
    Kerry, JA
    Trapani, JA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) : 17172 - 17177
  • [10] Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16
    Johnstone, RW
    Wei, W
    Greenway, A
    Trapani, JA
    [J]. ONCOGENE, 2000, 19 (52) : 6033 - 6042